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Abstract: Population-based prescription databases in Nordic countries have become a 
mainstay of epidemiologic research. Denmark has both national and regional population-based 
prescription databases. Aarhus University Prescription Database collects data on reimbursed 
medications dispensed at all community pharmacies of the North Denmark Region and the 
Central Denmark Region. The regions have a combined population of 1.8 million inhabitants, 
or one-third of the Danish population. Denmark’s primary health care sector, which includes 
general practitioners, specialists, and dentists, generates about 96% of the prescription sales, 
most of which are reimbursable and are dispensed by the community pharmacies. The Aarhus 
University Prescription Database combines the region’s pharmacy records in a single database, 
maintained and updated for research purposes. Each dispensation record contains patient-, drug-, 
and prescriber-related data. Dispensation records retain patients’ universal personal identifier, 
which allows for individual-level linkage to all Danish registries and medical databases. The 
linked data have many applications in clinical epidemiology, including drug utilization studies, 
safety monitoring, etiologic research, and validation studies.
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Prescription registries in Nordic countries have become a mainstay of epidemiologic 
research.1,2 Since its inception, in 1994, The Danish Registry of Medicinal Products 
Statistics has collected records on sales of all medicinal products nationwide, including 
individual-level data on outpatient dispensations and aggregate data on in-hospital 
dispensations.1 These data are accessible for research purposes via a database copy 
in Statistics Denmark. Advantages of the Registry of Medicinal Products Statistics 
for epidemiologic research include availability of records since the mid-1990s, the 
possibility to achieve large sample size due to nationwide coverage, and inclusion of 
all prescription medications regardless of reimbursement status. Important drawbacks 
of the Registry of Medicinal Products Statistics are potentially high costs associated 
with data acquisition from Statistics Denmark and restrictions on the export of raw 
data outside Statistics Denmark.2 These are barriers to potentially more widespread 
use of the Danish National Prescription Registry for epidemiologic research.1–3
In addition to the Registry of Medicinal Products Statistics, Denmark has two 
regional databases maintained for research purposes. One database is hosted by the 
University of Southern Denmark (the Odense University Pharmacoepidemiological 
Database), and the other database is hosted by Aarhus University (the Aarhus Univer-
sity Prescription Database). The regional databases are more easily accessible for data 
linkage and authorized export than the Registry of Medicinal Products Statistics, while Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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containing largely overlapping information. The regional 
databases thus represent an alternative source of population-
based prescription data. Recently, Furu et al provided a brief 
comparative overview of all Nordic prescription databases.1 
The early description of Aarhus University Prescription Data-
base was published in 1996,4 before Denmark’s municipal 
reform of 2007.5 This paper aims to provide a detailed and 
up-to-date description of the Aarhus University Prescription 
Database as a resource for epidemiologic research. Other 
names of this database used in published literature include 
“Pharmacoepidemiologic Prescription Database of North 
Jutland”6 and “Prescription Databases of the North Denmark 
and Central Denmark Regions”.1
Health care and prescribed 
medicine in Denmark
Denmark is a welfare state, with tax-financed universal access 
to health services.7 Except for emergencies, patients’ initial 
contact with the health care system is through their general 
practitioners, who provide referrals to hospitals and special-
ists as necessary. The primary health care sector is repre-
sented by about 4100 general practitioners, 1200 specialists, 
and 4600 dentists, as well as physiotherapists, chiropractors, 
and home nurses. There are about 300 community pharma-
cies.7 Prescriptions originating from the primary health care 
sector account for approximately 96% of the total volume of 
medicinal product sales in Denmark.8
Most prescription medications in Denmark are eligible 
for full or partial general reimbursement by the National 
Health Service (Sygesikringer). Adults (persons aged 
18 years or older) become eligible for reimbursement 
after exceeding 850 Danish kroner (∼114 Euro, ∼151 US 
dollars) in annual out-of-pocket expenditure for prescription 
medicine; children (persons under age 18 years) are exempt 
from the out-of-pocket expense requirement.9 Drugs 
ineligible for general reimbursement include sedatives, 
hypnotics, oral contraceptives, and over-the-counter (OTC) 
medicine. Conditional reimbursement, however, may be 
granted for prescription-only and OTC medicines, if they 
are prescribed for chronic conditions or to certain patient 
groups (eg, senior citizens).10 The Danish Medicines Agency 
(Lægemiddelstyrelsen, www.dkma.dk) regularly posts on 
its website updated rosters of generally and conditionally 
reimbursable medicines.10 Changes in reimbursement 
policies have been described, since 2005, on a dedicated 
website (http://www.dkma.dk/1024/visUKLSArtikel.
asp?artikelID = 6301).11
Population and period covered by 
the Aarhus University Prescription 
Database
Aarhus University Prescription Database covers the popula-
tion of the Central Denmark Region and the North Denmark 
Region. These are two of the five Danish regions, with a 
combined population of 1.8 million inhabitants, or about 
one-third of the total Danish population (Table 1, Figure 1). 
Following the municipal reform, which went into effect on 
1 January 2007, regions replaced counties as administrative 
units in Denmark. As a result, the Central Denmark Region 
and the North Denmark Region now encompass four former 
counties: Aarhus, North Jutland, Ringkjøbing, and Viborg, 
as well as seven municipalities of the former Vejle county 
(Table 1).5
Before the municipal reform, the Aarhus University 
Prescription Database received and merged prescription 
data from Aarhus, North Jutland, Ringkjøbing, and Viborg 
counties. Because counties started contributing at different 
times, they differ with respect to the earliest availability of 
Table 1. The Danish regions after the 2007 municipal reform and corresponding former counties
Region (Danish name) Population in 2009 Former counties included in the two  
regions
Coverage since
North Denmark Region (Region Nordjylland)  
www.rn.dk
580 515 Aarhus (one municipality)
North Jutland
Viborg (five municipalities)
1996
1989a
1998
Central Denmark Region (Region Midtjylland) 
www.regionmidtjylland.dk
1 247 732 Aarhus (all but one municipalities)
Ringkjøbing
Vejle (seven municipalitiesb)
Viborg (12 municipalities)
1996
1998
2007
1998
Data sourced from www.regioner.dk
Notes: aComplete coverage since February 1992; bAnnexed to the Central Denmark Region as a result of the 2007 municipal reform and are therefore represented in the 
regions’ prescription database from 2007 onwards.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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the data. Data from the former North Jutland county are 
available since 1992,6 from the former Aarhus county since 
1996, and from the former Viborg and Ringkjøbing counties 
since 1998. After the municipal reform, the Aarhus University 
Prescription Database has been merging prescription data 
from the community pharmacies of the Central Denmark 
Region and the North Denmark Region.
Data flow
Ambulatory patients redeem prescriptions at community 
pharmacies, which electronically transmit dispensation 
data to the regional subdivisions of the National Health 
Service for reimbursement. Prescription reimbursement 
records must be de-identified within two months of sale.2 
In order to enable individual-level linkage of prescription 
data to other medical databases, patient records need to 
remain identifiable. According to an agreement with Aarhus 
University, the National Health Service subdivisions of the 
Central Denmark Region and the North Denmark Region 
transfer individually identifiable dispensation data collected 
from the community pharmacies to the Department of 
Clinical Epidemiology at Aarhus University Hospital. The 
transfer is conducted using a password-protected encrypted 
connection, and the data are kept on a secure server. Data 
protection is further discussed below. The dispensation data 
are also reported to the Registry of Medicinal Products 
Statistics.1
Variables
One drug dispensation represents the unit of observation in 
the Aarhus University Prescription Database. Each line of 
record contains the following variables:
1.  Patient’s identifier (the so-called CPR number), which 
is a unique 10-digit numeric code assigned at birth or 
immigration by Denmark’s Central Personal Registry. The 
first six digits of the CPR number correspond to the day, 
month, and year of birth, and the last digit encodes sex 
(odd digits for male; even digits for female).12 Prescrip-
tions for children younger than 16 years were registered 
under the CPR numbers of their parents until April 1, 1996 
and under the children’s own CPR numbers thereafter;
2.  Date of sale, which, in combination with the CPR number, 
enables calculation of the patient’s age at dispensation;
3.  Type of drug, which is coded according to the anatomical 
therapeutic chemical (ATC) classification;13
4.  Universal product number (Varenummer), which encodes 
medication name, strength, pack size, dose units (eg, mg 
or mL), defined daily dose (DDD), and manufacturer;
5.  Provider code, which corresponds to a clinic, a practice, or 
a single physician. The provider code enables identification 
of the prescriber’s specialty, name, and address, and in case 
of single practitioners, their age and sex.
What is registered in the Aarhus 
University Prescription Database?
Aarhus University Prescription Database records prescription 
medications that receive general or conditional reimburse-
ment dispensed at the community pharmacies of the Central 
Denmark Region and the North Denmark Region. In 2009, 
14.9 million dispensations were reported to the database. 
Table 2 and Figure 2 show the distribution of these dispensa-
tions by the major ATC classification group. Dispensations 
in group C (cardiovascular system) account for more than 
one-quarter of all dispensations, followed by dispensations 
in group N (nervous system), which account for more than 
one-fifth (Figure 2).
Thirty ATC codes account for half of all dispensations. The 
five most frequently dispensed medications are simvastatin 
(ATC code C10AA01), acetylsalicylic acid (ASA, B01AC06), 
paracetamol (N02BE01), metoprolol (C07AB02), and 
bendroflumethiazide (C03AB01) (Table 3).
The distribution of dispensations reflects the extent of by-
prescription use of ASA and paracetamol, which can be sold 
over the counter. ASA is reimbursed (and therefore recorded) 
if prescribed for specific indications, including primary 
and secondary prophylaxis of cardiovascular diseases.10 
Figure 1. The five regions of Denmark formed by the 2007 municipal reform (source: 
www.fm.dk).a
Note: aEnglish names are given according to Danish Regions.5Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Therefore, prescriptions for ASA recorded in the Aarhus 
University Prescription Database are expected to originate 
primarily from persons older than 55 years, or those with 
increased risk of cardiovascular morbidity. Paracetamol is 
reimbursable if prescribed for chronic pain.10 An estimated 
11% of ASA and 80% of paracetamol packages prescribed 
in the primary sector are not reimbursed8 and therefore not 
recorded in the Aarhus University Prescription Database. 
Thus, for conditionally reimbursed medications, the pro-
portion of dispensations recorded in the Aarhus University 
Prescription Database varies by pharmaceutical. The Internet-
based database www.medstat.dk provides on-demand sta-
tistics (in Danish) on annual sales of pharmaceuticals with 
and without reimbursement in all sectors of health care. The 
aggregate statistics are available for each medication sold in 
Denmark and can be defined in packages or in daily doses. 
Using these data, degree of underascertainment of medica-
tion use due to lack of reimbursement can be estimated on 
a case-by-case basis.
What is not registered
The Aarhus University Prescription Database does not 
contain data on drugs that do not receive general or con-
ditional reimbursement or drugs dispensed outside the 
community pharmacies of the two regions. The non-reim-
bursable medications include, for example, oral contracep-
tives and OTC medications (unless prescribed for chronic 
conditions, as discussed above). Reimbursed medications 
dispensed outside community pharmacies include medica-
tions dispensed directly to patients in hospitals or outpatient 
clinics. These include, for example, outpatient anti-neoplastic 
treatments, antiretroviral treatments for patients with human 
immunodeficiency virus infection, or substitution therapy for 
substance abusers.14 For drug-specific information regarding 
reimbursement rules9,10 and distribution of pharmaceutical 
sales according to reimbursement status and health care 
sector,8 the readers are referred to the relevant publications 
by the Danish Medicines Agency that are freely available on 
the Internet, the latter publication also in English.8
Quality of data
Pharmacies use bar code scanning to enter drug information 
into their database, making drug-related data entry errors 
highly unlikely. Potential dispensation of a wrong drug to a 
patient cannot be detected by examining the electronic data, 
but the frequency of such occasions is assumed to be negligible 
to meaningfully affect most study results. For the population 
of the two regions, dispensation records of reimbursed medi-
cations from community pharmacies, which are reported to 
the Aarhus University Prescription Database, are expected to 
Table  2  Distribution  of  prescribed  medicine  recorded  in  the 
Aarhus University Prescription Database according to the 14 main 
ATC anatomic groups (2009)
Anatomical main ATC  
group, alphabetically13
Number Percent
A Alimentary tract  
and metabolism
1,580,837 10.61
B Blood and blood  
forming organs
972,851 6.53
C Cardiovascular  
system
3,902,845 26.19
D Dermatologicals 416,072 2.79
g genito-urinary system  
and sex hormones
437,840 2.94
h Systemic hormonal preparations,  
excluding sex hormones and insulins
402,689 2.70
J Anti-infectives for systemic use 1,024,331 6.87
L Antineoplastic and  
immunomodulating agents
38,065 0.26
M Musculoskeletal system 887,667 5.96
N Nervous system 3,420,504 22.96
P Antiparasitic products,  
insecticides, and repellents
79,434 0.53
R Respiratory system 1,345,013 9.03
S Sensory organs 384,721 2.58
V Various 7,277 0.05
Total 14,900,146 100
Abbreviations: ATC, anatomical therapeutic chemical.
23%
26%
11%
9%
7%
7%
6%
3%
3%
3%
3%
N
A
R
J
B
M
G
D
HS
C
Figure 2. Percentage of dispensations recorded in the Regional Prescriptions Databases 
of the North Denmark Region and Central Denmark Region by anatomical therapeutic 
chemical group (2009).Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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be the same as records reported to the Registry of Medicinal 
Products Statistics. A cross-tabulation, at our department, of 
records with available data from both sources confirmed this 
expectation (unpublished data).
An estimated completeness of the Aarhus University 
Prescription Database is 96%, based on cross-tabulation of 
insulin prescriptions with hospitalization records of diabetes 
mellitus in the former North Jutland county.4 However, 
completeness may vary by drug type. Furthermore, although 
dispensation record represents patients with primary adherence 
(those who purchase medications), it reflects neither the fact 
nor the exact timing of the actual medication intake.
Record linkage and use  
of data in clinical research
Thanks to patient-identifiable data in the Aarhus University 
Prescription Database, it is technically easy to link it to all 
other Danish registries, both nationwide and regional, using 
the CPR number. Because Denmark’s registries are numerous 
and far-reaching even by the standards of Nordic countries,15 
such linkage opens many possibilities for epidemiologic and 
interdisciplinary research. Linkage can be done, for example, 
to migration and vital status data in the Civil Registration 
System,12 hospitalization records in the Danish National Patient 
Registry, cancer diagnoses in the Danish Cancer Registry, 
Table 3 ATC codes of the 30 most frequently dispensed prescription medications in 2009. These account for half of all dispensations 
recorded in the Aarhus University Prescription Database in 2009
Rank ATC code Generic name Therapeutic group Dispensations
Number Percent Cumulative percent
1 C10AA01 Simvastatin Lipid modifying agents 586,994 3.94 3.94
2 B01AC06 Acetylsalicylic acid Platelet aggregation inhibitors 575,459 3.86 7.80
3 N02BE01 Paracetamol Analgesics 561,960 3.77 11.57
4 C07AB02 Metoprolol Beta-blocking agents 397,647 2.67 14.24
5 C03AB01 Bendroflumethiazide  
and potassium
Diuretics 373,883 2.51 16.75
6 N02AX02 Tramadol Analgesics 373,566 2.51 19.26
7 M01AE01 Ibuprofen Anti-inflammatory and 
antirheumatic products
351,022 2.36 21.61
8 J01CE02 Phenoxymethylpenicillin Antibacterials for systemic use 342,875 2.30 23.92
9 C03CA01 Furosemide Diuretics 337,188 2.26 26.18
10 C08CA01 Amlodipine Calcium channel blockers 325,525 2.18 28.36
11 N06AB04 Citalopram Psychoanaleptics 308,399 2.07 30.43
12 A12BA01 Potassium chloride Mineral supplements 302,868 2.03 32.47
13 A10BA02 Metformin Drugs used in diabetes 232,332 1.56 34.02
14 C09AA02 Enalapril Agents acting on the  
renin-angiotensin system
206,163 1.38 35.41
15 C09AA05 Ramipri 199,661 1.34 36.75
16 h03AA01 Levothyroxine sodium Thyroid therapy 176,487 1.18 37.93
17 A02BC03 Lansoprazole Drugs for acid-related disorders 171,094 1.15 39.08
18 N02AA05 Oxycodone Analgesics 154,468 1.04 40.12
19 g03CA03 Estradiol Sex hormones 150,859 1.01 41.13
20 R03AC02 Salbutamol Drugs for obstructive airway 
diseases
138,253 0.93 42.06
21 A02BC05 Esomeprazole Drugs for acid-related disorders 134,029 0.90 42.96
22 N06AX11 Mirtazapine Psychoanaleptics 129,964 0.87 43.83
23 B01AA03 Warfarin Antithrombotic agents 128,336 0.86 44.69
24 A02BC01 Omeprazole Drugs for acid-related disorders 120,269 0.81 45.50
25 N06AB10 Escitalopram Psychoanaleptics 119,383 0.80 46.30
26 B01AC07 Dipyridamole Antithrombotic agents 119,024 0.80 47.10
27 R03AK06 Salmeterol  Drugs for obstructive airway 
diseases
117,433 0.79 47.89
28 R03BA02 Budesonide Drugs for obstructive airway 
diseases
115,090 0.77 48.66
29 R03BB04 Tiotropium bromide Drugs for obstructive airway 
diseases
113,320 0.76 49.42
30 M01AX05 glucosamine Anti-inflammatory and 
antirheumatic products
108,622 0.73 50.15
Abbreviation: ATC, anatomical therapeutic chemical.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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or birth records in the Danish Medical Birth Registry.16 
Linkage to the birth records is a valuable resource for studies 
of medication safety in pregnancy. Birth records contain both 
maternal and paternal CPR numbers of live- or still-born 
babies, allowing linkage of prescription and hospital records 
of parents and children. Examples of studies involving linkage 
to different data sources are given below. Even unlinked dis-
pensation data can provide a wealth of information. Because 
each dispensation is identified by CPR number, it is possible 
to study patterns of drug utilization by patient age and sex 
and to reconstruct individual dispensation trajectories over 
time. The availability of prescription data since the mid-1990s 
enables the conduct of intergenerational studies. Besides Den-
mark, Finland is the only other Nordic country in which this is 
possible, because of the availability of prescription data since 
the 1990s, eg, parental use of medication before conception 
or birth can be examined for today’s young adults.1
Data access
The Danish Act on Processing of Personal Data (Person-
dataloven) provides the legal basis for the ability of public 
institutions, including universities, to retain person-identifiable 
health data for research purposes.17 In order to access the data 
from the Aarhus University Prescription Database, research-
ers may apply to the Department of Clinical Epidemiology, at 
Aarhus University Hospital (www.kea.au.dk). Furthermore, 
use of any health data requires project-specific permission 
from the Data Protection Agency (Datatilsynet, www.
datatilsynet.dk), and often additional permission for link-
age from the National Board of Health (Sundhedsstyrelsen, 
www.sst.dk).
Examples of studies conducted  
with data from the Aarhus 
University Prescription Database
Reports of studies based on data from the Aarhus University 
Prescription Database have been published in several major 
international peer-reviewed journals and include both safety 
investigations and epidemiologic studies that use prescrip-
tion record as a proxy measure of disease. A non-exhaustive 
list of examples includes investigations among pregnant 
women based on linkage to birth registry, including safety 
of non-steroidal anti-inflammatory drugs (NSAIDs),18 lorata-
dine,19 fluconazole,20 selective serotonin reuptake inhibitors 
(SSRIs),21 and clomifene.22 Nørgaard et al used linkage with 
hospitalization records to investigate risk of miscarriage 
among pregnant users of pivmecillinam, while using data on 
the women’s dispensation of anti-epileptic and anti-diabetic 
medications to control potential confounding by epilepsy and 
diabetes.23 Likewise, by linkage to hospitalization records, 
Johnsen et al examined the risk of myocardial infarction 
among users of several NSAIDs,24 Fryzek et al studied cancer 
risk among women using antihypertensive medications,25 
Nørgaard et al used prescriptions for SSRIs as a marker of 
depression in a study of acute pancreatitis,26 and Lash et al 
and Cronin-Fenton et al studied the role of tamoxifen and 
SSRIs in preventing the recurrence of breast cancer.27–29 
Finally, several investigations demonstrated socioeconomic 
differences in drug utilization by linking prescription dispen-
sation records from Aarhus University Prescription Database 
to individual-level socioeconomic indicators.30–33
Conclusion
Routinely recorded person-identifiable prescription data have 
many uses, including post-approval research or etiologic 
studies. The Aarhus University Prescription Database con-
tains, with few exceptions, dispensation data on reimbursed 
medicine for the entire population of two Danish geographic 
regions representing one-third of the country’s population. 
The data are accessible for research and are linkable to all 
other Danish databases and registries. The main drawbacks 
of the Aarhus University Prescription Database are a lack of 
nationwide coverage and the absence of data of certain medi-
cation types. At the same time, a vast majority of prescription 
dispensations are routinely recorded, with more than 15 years’ 
worth of follow-up data accumulated to date. Thus, the Aar-
hus University Prescription Database represents a valuable 
research tool for many epidemiologic applications.
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